Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
08/2008
08/14/2008US20080194565 5-Phenyl-Pentanoic Acid Derivatives as Matrix Metalloproteinase Inhibitors for the Treatment of Asthma and Other Diseases
08/14/2008US20080194557 methods of treating, managing and preventing pain, inflammation, cancer, and ocular diseases and disorders, and to compounds and pharmaceutical compositions useful in such methods
08/14/2008US20080194541 Anti-Inflammatory Agents
08/14/2008US20080194524 Compounds For the Inhibition of Undesired Cell Proliferation and Use Thereof
08/14/2008US20080194510 Substances, Compositions and Methods for Preventing and Treating Immune-Mediated Inflammatory Disorders
08/14/2008US20080193560 Use of arsenic compounds for treatment of pain and inflammation
08/14/2008US20080193447 Gamma-1 and gamma-3 anti-human cd23 monoclonal antibodies and use thereof as therapeutics
08/14/2008US20080193415 HSA-free formulations of interferon-beta
08/14/2008US20080193382 preventing or delaying development or progression of a condition associated with inflammation caused by necrosis, comprising administering drugs that inhibits interleukin signalling
08/14/2008DE202007015195U1 Korianderöl-Fraktionen enthaltende Zubereitungen und deren Verwendung zur Herstellung eines Arzneimittels oder kosmetischen Mittels Coriander oil fractions containing preparations and their use for the manufacture of a medicament or cosmetic agent
08/14/2008CA2845299A1 Use of arsenic compounds for treatment of pain and inflammation
08/14/2008CA2845292A1 Use of arsenic compounds for treatment of pain and inflammation
08/14/2008CA2678193A1 Aza-bridged-ring compound
08/14/2008CA2677661A1 Tricyclic compounds
08/14/2008CA2677457A1 New compounds, methods for their preparation and use thereof
08/14/2008CA2677388A1 Use of arsenic compounds for treatment of pain and inflammation
08/14/2008CA2677233A1 Prophylactic agent for autoimmune disease
08/14/2008CA2676498A1 [1,2,3] triazolyl substituted quinolines and coumarins as inhibitors of leukotriene biosynthesis
08/14/2008CA2676139A1 Composition comprising terpene compounds and methods for inhibiting nerve transmission
08/14/2008CA2675357A1 6-benzyl-2,3,4,7-tetrahydro-indolo [2, 3-c] quinoline compounds useful as pde5 inhibitors
08/13/2008EP1956017A1 Substituted 2-(2,6-dioxopiperidin-3-yl)-phthalimides and method of reducing TNF alpha levels
08/13/2008EP1956009A1 Aromatic compound
08/13/2008EP1955697A1 2-aminobenzamide derivative
08/13/2008EP1954698A1 Spirocyclic compounds as hdac inhibitors
08/13/2008EP1954694A1 Imidazole derivatives as nitric oxide synthase dimerisation inhibitor
08/13/2008EP1954320A2 Compositions comprising lipoxygenase inhibitors and cyclodextrin
08/13/2008EP1954314A2 Preparation, comprising iron(iii) complex compounds and redox-active substances
08/13/2008EP1954275A2 Pharmaceutical compositions comprising buprenorphine
08/13/2008EP1954245A2 Compositions of lipoxygenase inhibitors
08/13/2008EP1954132A2 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
08/13/2008EP1954128A2 Diphenylmethane derivatives as inhibitors of leukotriene biosynthesis
08/13/2008EP1572672B1 Benzoxazocines and their use as monoamine-reuptake inhibitors
08/13/2008EP1572632B1 Tetrahydro-naphthalene derivatives as vanilloid receptor antagonists
08/13/2008EP1565183B1 Rapamycin and il-10 for the treatment of autoimmune diseases
08/13/2008EP1537867B1 Method of photodynamic diagnosis for vascular diseases
08/13/2008EP1505992B1 Method for reducing pain using oncolytic viruses
08/13/2008EP1501803B1 Tetrahydropyranyl cyclopentyl tetrahydroisoquinoline modulators of chemokine receptor activity
08/13/2008EP1489088B1 Novel alpha-amino-n-(diaminophosphinyl)lactam derivative
08/13/2008EP1450825B1 Use of selenite-containing compounds to be topically or buccally administered
08/13/2008EP1429914B1 Apparatus for manufacturing dosage forms
08/13/2008EP1389098B1 Delivery of antipsychotics through an inhalation route
08/13/2008EP1389097B1 Delivery of compounds for the treatment of parkinsons through an inhalation route
08/13/2008EP1322309B1 High affinity small molecule c5a receptor modulators
08/13/2008EP1137773B1 Growth factor homolog zvegf3
08/13/2008EP1064308B1 Methods for identifying inducers and inhibitors of proteolytic antibodies, compositions and their uses
08/13/2008EP0647137B1 Glycine receptor antagonists and the use thereof
08/13/2008CN101243086A Indoli zine derivatives and their use as CRTH2 antagonists
08/13/2008CN101243072A Piperidine derivatives useful as histamine H3 antagonists
08/13/2008CN101243051A P38 MAP kinase inhibitors and methods for using the same
08/13/2008CN101242850A Composition, function and use of xanthoceras sorbifolia extract and compound isolated from same, method for preparing same
08/13/2008CN101242832A Fused pyrazole as p38 MAP kinase inhibitors
08/13/2008CN101242831A Prophylactic and/or therapeutic method for rheumatoid arthritis
08/13/2008CN101240017A A uro-genital disease treatment system
08/13/2008CN101240007A Oleanane triterpene compound with containing multiple unsaturated double bonds and use thereof
08/13/2008CN101240006A Oleanane triterpene compound with C ring containing conjugated double bond and use thereof
08/13/2008CN101240000A Novel thiophenylglycoside derivatives, methods for production thereof, medicaments comprising said compounds and use thereof
08/13/2008CN101239972A Heterocyclic n-aryl carboxamides as cytokine inhibitors
08/13/2008CN101239901A Method for preparing ibuprofen arginine salt
08/13/2008CN101239171A Viscera muscles and bones pain-eliminate plaster and preparation thereof
08/13/2008CN101239168A Composition with ease pain anti-inflammatory action
08/13/2008CN101239159A Chinese medicinal composition for treating rheumatoild disease and preparation thereof
08/13/2008CN101239154A Medicament for treating protrusion of lumbar vertebral disc and pain of neck, shoulder, waist and leg bone and preparation thereof
08/13/2008CN101239136A Medicament for treating rheumatism
08/13/2008CN101239115A Medicaments for treating pain of knee joint
08/13/2008CN101239103A Clearing heat and detoxication traditional Chinese medicine preparation and preparation thereof
08/13/2008CN101239100A Application of Sichuan chinaberry extract in pharmaceutical and extracting method thereof
08/13/2008CN101239093A Active component in albizia julibrissin with inhibiting angiogenesis function and preparation method and application thereof
08/13/2008CN101239078A Placenta immunoregulation medicament capsule
08/13/2008CN101239076A Blood plasma immunoregulation medicament capsule
08/13/2008CN101239018A Multilayer copolymerized compound membrane soft bagged inosine in sodium chloride injection composition and its manufacturing method
08/13/2008CN101238890A Tea extract sugar and its preparing method
08/13/2008CN100410661C Quality control method of heat-clearing toxin-removing cold-treating honeysuckle injection
08/13/2008CN100410250C Spiroheterocyclic compoundsus reversible inhibitors of cysteine proteases
08/13/2008CN100409891C Pure Chinese medicinal preparation for activating blood circulation, removing blood stasis and relieving pain
08/13/2008CN100409886C Medicinal liquor for bone health
08/13/2008CN100409861C Eshu oil
08/13/2008CN100409858C Composition of luffa seed oil
08/13/2008CN100409853C Chinese medicine prescription for treatment of appendicitis
08/13/2008CN100409847C Transdermal delivery system for alkaloids of aconitum species
08/13/2008CN100409842C Heiguidou oil
08/12/2008US7411072 e.g. 5-(10,11-Dihydro-dibenzo[a,d]cyclohepten-5-ylidenemethyl)-3H-benzooxazol-2-one; antiinflammatory, antidiabetic agent; electrolytes and water retention modulator; hypotensive, hypoglycemic agent; arrhythmias, myocardial fibrosis, osteoporosis, polyuria, polydipsia, Crohn's disease
08/12/2008US7411055 Genetic engineering
08/12/2008US7411050 Bioassay for detection of receptor activated nuclear factor kappa beta ligand (RANKL); identifying modulator immune and inflammatory response
08/12/2008US7411041 DCRS5 polypeptides
08/12/2008US7411001 Oxygenated esters of 4-iodo phenylamino benzhydroxamic acids
08/12/2008US7410997 relaxing action of tracheal smooth muscles, inhibition of airway hypersensitivity and inhibition of infiltration of inflammatory cells into the airway; useful as antiasthmatic drugs
08/12/2008US7410994 (6-methanesulfonyl-3-phenylsulfanyl-1H-indol-2-yl)-methanol; cyclooxygenase, prostaglandin G/H synthase inhibitors; antiinflammatory and analgesic agents; autoimmune diseases; Alzheimer's disease and osteoporosis of women after menopause
08/12/2008US7410991 Pyrazolidinone compounds as ligands of the prostaglandin EP2 and/or EP4 receptors
08/12/2008US7410987 Treating pruritus or pain, particularly that caused by a rheumatic disease, by administering a 2-[o-(aminoalkoxy)phenyl])-3-acylbenzothiazoline, e.g., 3-Acetyl-6-chloro-2-[2-(3-(N-(2-hydroxyethyl)-N-isopropylamino)-propoxy)-5-methoxyphenyl]benzothiazoline
08/12/2008US7410986 For therapy of inflammatory symptoms; tumors, ischemia and tumor
08/12/2008US7410984 novel pyridone derivatives capable of inhibiting alpha 4 integrin mediated cell adhesion; to treat chronic inflammatory diseases; 3-(4-{2-Oxo-3-[4-(3-o-tolyl-ureido)phenyl]-2H-pyridin-1-ylmethyl}phenyl)propionic acid; hydrolysis
08/12/2008US7410972 Compounds
08/12/2008US7410961 2,6-disubstituted piperiddines as modulators
08/12/2008US7410955 Therapeutic use of agonist ligands specific to G2A receptor
08/12/2008US7410945 Treatment of inflammatory bowel disease
08/12/2008US7410806 Screening for agents that inhibit complex formation using competitive binding assay based on fluorescence depolarization or internal energy transfer; antiinflammatory
08/12/2008US7410652 Controlled release and taste masking oral pharmaceutical composition
08/12/2008US7410651 Controlled release and taste masking oral pharmaceutical composition
08/12/2008US7410642 Assays and therapies for latent viral infection
08/12/2008CA2487331C Anti-inflammatory compositions and methods of use
1 ... 465 466 467 468 469 470 471 472 473 474 475 476 477 478 479 480 481 482 483 484 485 ... 1272